GREENFIELD PROJECT DEVELOPMENT AT SOLA-SCIENCE CITY

the project demonstrates exceptional financial viability, evidenced by its impressive 41% Internal Rate of Return (IRR) and 85% Return on Investment (ROI). The unique product mix, particularly the emphasis on healthcare commercial spaces, further strengthens its market position. The joint developers' substantial gain of 185% on their initial 390-crore investment reflects the project's robust financial standing and attractive returns. The strategic focus on healthcare commercial spaces aligns with market demands and positions the project as a distinctive and valuable proposition in the Sola micro market. The evident success driven by demand in this specific market reinforces the venture's potential as a highly lucrative opportunity. These compelling financial indicators, combined with the project's adaptability to market dynamics, instill confidence in its long-term profitability and sustainability.